CoChat

Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders

Open access
Moradi, Seyed Zachariah, Momtaz, Saeideh, Bayrami, Zahra, Farzaei, Mohammad Hosein, Abdollahi, Mohammad · 2020 · Frontiers in Bioengineering and Biotechnology
Cited by 180

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Nanotechnology is one of the methods that have been able to influence human life in different ways and is a substantial tool that assists to overcome the multiple limitations in the treatment of various diseases, especially neurodegenerative disorders (NDs). Various nanostructures such as polymer nanoparticles, lipid nanoparticles, nanoliposomes, nano-micelle, carbon nanotubes (CNTs), besides different vehicle systems including poly lactic-co-glycolic acid, lactoferrin, polybutylcyanoacrylate and some others significantly increased the effectiveness, reduced the side effects, enhanced the stability, and improved the pharmacokinetics of several drugs. NDs belong to a group of annoying and debilitating disorders involving millions of people worldwide. Privious studies revealed that several nano formulations from a number of natural products such as curcumin (Cur), quercetin (QC), resveratrol (RSV), piperine (PIP), Ginkgo biloba, and Nigella sativa showed significant effectiveness in improving the condition of patients with NDs. The blood-brain barrier (BBB) is the main limitation of NDs management. In this review, we have attempted to discuss the effects of herbal-based nano formulation that used to treat such diseases. In summary, herbal-based nanoformulations seem to be significant in the treatment of NDs, alone or in combination with other drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fbioe.2020.00238

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

Metadata

Authors
Moradi, S. Z., Momtaz, S., Bayrami, Z., Farzaei, M. H., & Abdollahi, M.
Venue
Frontiers in Bioengineering and Biotechnology
Published
2020-04-07
Volume
8
Pages
238-238
ISSN
2296-4185 (ISSN-L)
OpenAlex
W3015599023
Cited by
180
References
30
FWCI
7.63
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.